Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Global pharma major, Lupin announced that it has received tentative approval fr...
In this GEN webinar, Justin Byers and Daniel Lin-Arlow, PhD, examine how enzymat...
After six years of construction, Fort Leonard Wood marked the opening of the new...
Alexandria Supino, AIA, NCARB, EDAC, recently joined Gresham Smith’s Charlotte, ...
Located on its Health Sciences Campus in Columbia, S.C., the University of South...
Christian Kyle Jordan Perry recently joined DesignGroup as Senior Lab Planner. ...
Researchers identified the synaptic protein EPAC2 as a potential therapeutic tar...
A University of Bath, University of Oxford, and Johns Hopkins team is using orga...
A new study compares two prevailing models, cuprizone (CPZ) and lysophosphatidyl...
Do’s and Don’ts for Healthier Skin All Summer Long After months of covering up...
Medical school is not just more school, it’s essentially a full-time job as you ...
Advances in individualized therapies targeting specific genetic conditions offer...
Jascayd is said to be the first phosphodiesterase 4B (PDE4B) inhibitor with anti...
Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sci...
Annora Pharma, the formulations subsidiary of Hetero Group and a leading Indian...